此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Pupillary Light Reflex to Predict Post-Spinal Hypotension in Elective Cesarean Delivery

2026年6月25日 更新者:Tarik Saber Sarhan、Al-Azhar University

Pupillary Light Reflex for Predicting Hypotension Risk After Spinal Anesthesia for Elective Cesarean Section: A Prospective Observational Cohort Study

This prospective observational cohort study investigates whether pre-anesthetic pupillary light reflex (PLR) parameters can predict the risk of hypotension following spinal anesthesia in women undergoing elective cesarean section. Spinal anesthesia-induced hypotension is common, with reported incidence rates of 50-90%, and current predictors such as baseline blood pressure and BMI have limited accuracy. PLR, a sensitive marker of autonomic nervous system balance, may offer a simple, objective, and non-invasive tool for identifying patients at higher risk. The study evaluates pupillary reaction latency and other PLR parameters and correlates them with post-spinal blood pressure changes to determine their predictive value.

研究概览

详细说明

Spinal anesthesia is the standard technique for elective cesarean delivery, yet it is frequently associated with maternal hypotension due to sympathetic blockade. According to the study protocol, spinal anesthesia-induced hypotension (SAIH) occurs in 50-90% of cases, and currently available predictors-including baseline blood pressure, BMI, and block height-demonstrate limited accuracy (AUC <0.65). The pupillary light reflex (PLR) is a sensitive indicator of autonomic nervous system balance, and pupillary reaction latency may reflect parasympathetic conduction efficiency. As noted in the protocol, no published studies have evaluated PLR as a predictor of hypotension after spinal anesthesia in obstetric patients.

This prospective observational cohort study aims to determine whether pre-anesthetic PLR parameters, particularly pupillary reaction latency, can predict the occurrence and severity of hypotension following spinal anesthesia for elective cesarean section. Additional pupillometry parameters-including baseline diameter, constriction velocity, and minimum diameter-will also be assessed. Measurements are obtained using a handheld pupillometer after 5 minutes of dark adaptation, with three readings taken at 60-second intervals.

Following spinal anesthesia with hyperbaric bupivacaine and fentanyl, maternal blood pressure is monitored every 5 minutes for the first 20 minutes. The primary outcome is hypotension, defined as a >20% decrease in systolic blood pressure. Secondary outcomes include severe hypotension, vasopressor requirements, maternal symptoms, and neonatal Apgar scores and umbilical artery pH.

Statistical analysis includes ROC curve evaluation, Youden's index for cutoff determination, and multivariate logistic regression. The study involves no interventions beyond routine care, and pupillometry is non-invasive and safe. Findings may support the development of a novel, objective, and clinically useful predictor for SAIH in obstetric anesthesia.

研究类型

观察性的

注册 (估计的)

200

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

取样方法

非概率样本

研究人群

Pregnant women (ASA II), aged 18-45 years, with term singleton pregnancies undergoing elective cesarean section under spinal anesthesia at Al-Azhar University Hospital, Damietta. Participants are evaluated using pre-anesthetic pupillometry and routine perioperative monitoring.

描述

Inclusion Criteria:

ASA II Term pregnancy ≥37 weeks Singleton pregnancy Elective cesarean section Age 18-45 years Written informed consent

Exclusion Criteria:

Emergency cesarean section Hypertensive disorders Diabetes mellitus Cardiovascular disease Neurological or autonomic disorders Ophthalmic disease Medications affecting autonomic function BMI >40 kg/m² Failed spinal anesthesia

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Elective Cesarean Section Cohort
Pregnant women (ASA II, term ≥37 weeks) undergoing elective cesarean section under spinal anesthesia. Participants undergo pre-anesthetic pupillometry and routine perioperative monitoring. No interventions are administered beyond standard clinical care.
This study does not involve any investigational drugs, devices, or therapeutic interventions. Pupillometry is a non-invasive measurement performed as part of the observational assessment and is not considered an intervention.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of Hypotension After Spinal Anesthesia
大体时间:0-20 minutes after spinal anesthesia
Hypotension defined as a >20% decrease in systolic blood pressure from baseline within the first 20 minutes after spinal anesthesia administration. Blood pressure is measured every 5 minutes as per protocol.
0-20 minutes after spinal anesthesia

次要结果测量

结果测量
措施说明
大体时间
Incidence of Severe Hypotension
大体时间:0-20 minutes after spinal anesthesia
Severe hypotension defined as systolic blood pressure <80 mmHg or requiring vasopressor administration.
0-20 minutes after spinal anesthesia
Total Vasopressor Dose Administered
大体时间:Intraoperative period (first 20 minutes post-spinal)
Total amount of vasopressor medication administered to treat hypotension following spinal anesthesia.
Intraoperative period (first 20 minutes post-spinal)
Maternal Symptoms Associated With Hypotension
大体时间:Intraoperative period
Assessment of maternal symptoms including nausea, vomiting, dizziness, or discomfort associated with hypotension.
Intraoperative period
Neonatal Apgar Scores
大体时间:1 minute and 5 minutes postpartum
Apgar scores at 1 and 5 minutes after delivery.
1 minute and 5 minutes postpartum
Umbilical Artery pH
大体时间:Immediately after delivery
Measurement of umbilical artery blood pH to assess neonatal acid-base status.
Immediately after delivery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年6月28日

初级完成 (估计的)

2026年9月30日

研究完成 (估计的)

2026年10月31日

研究注册日期

首次提交

2026年6月25日

首先提交符合 QC 标准的

2026年6月25日

首次发布 (实际的)

2026年7月1日

研究记录更新

最后更新发布 (实际的)

2026年7月1日

上次提交的符合 QC 标准的更新

2026年6月25日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • DFM-IRB 00012367- 26-06-005

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅